NTOX-11. DISEASE OUTCOMES, TOXICITY PROFILES, AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RECURRENT GLIOBLASTOMA RECEIVING INTRA-ARTERIAL CARBOPLATIN SALVAGE THERAPY

INTRODUCTION: Glioblastoma (GBM) remains the most aggressive entity of primary brain tumors with a reported median survival of 14.6 months, despite maximal therapy. While the paradigm developed by Stupp et. al. is considered to be standard care treatment for primary GBM, there is no consensus regard...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Babcock, Anna, Hultman, Meghan, Bruns, Patricia, Gilliland, Katheryn, Schrecengost, Amy, Trusheim, John, Banerji, Nilanjana
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692033/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.678
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados